My Cart

GAD1

GAD1 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
GA1-H5543
Human
InsectCells
Human GAD1 / GAD67 Protein, His Tag
Add to Cart
Total: 1
  • 1

GAD1 Background

Glutamate decarboxylase or glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the decarboxylation of glutamate to gamma-aminobutyric acid (GABA), the major inhibitory transmitter in higher brain regions, and putative paracrine hormone in pancreatic islets. GAD uses pyridoxal-phosphate (PLP) as a cofactor.Two molecular forms of GAD (65 kDa and 67 kDa) are highly conserved and both are expressed in the CNS, pancreatic islet cells, testis, oviduct and ovary. The isoforms are regionally distributed cytoplasmically in the brains of rats and mice. GAD65 is an ampiphilic, membrane-anchored protein (585 a.a.), and is responsible for vesicular GABA production. GAD67 is cytoplasmic (594 a.a.), and seems to be responsible for significant cytoplasmic GABA production.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Dapirolizumab pegolAnti-CD40L-Fab; Anti-CD40L-Fab-PEG; CDP-7657; CD40L - Fab; BIIB-133Phase 3 ClinicalBiogen Inc, UcbAutoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Lupus Erythematosus, Systemic; Skin and Connective Tissue Diseases
Details
DazodalibepVIB-4920; MEDI-4920; HZN-4920(Horizon Therapeutics); UNII-HN5US76BWF; WHO-11399Phase 3 ClinicalMedimmune Llc, Horizon Therapeutics PLCRejection of renal transplantation; Sjogren's Syndrome; Arthritis, Rheumatoid; Lupus Nephritis; Rejection of organ transplantation; Sjogren-Larsson Syndrome
Details
FrexalimabINX-021; SAR-441344Phase 3 ClinicalImmunext IncDiabetes Mellitus, Type 1; Sjogren's Syndrome; Multiple Sclerosis; Lupus Erythematosus, Systemic; Glomerulosclerosis, Focal Segmental; Sjogren-Larsson Syndrome; Glomerulonephritis
Details
Anti-CD40L antibody (Bristol-Myers Squibb)Phase 2 ClinicalBristol-Myers Squibb CompanyImmunologic Deficiency Syndromes
Details
AdCD40LPhase 2 ClinicalUppsala UniversityUrinary Bladder Neoplasms; Melanoma
Details
TegoprubartAT-1501Phase 2 ClinicalAls Therapy Development InstituteDiabetes Mellitus, Type 1; Rejection of renal transplantation; Glomerulonephritis, IGA; Diabetes Mellitus; Amyotrophic Lateral Sclerosis
Details
Delolimogene mupadenorepvecLOAd-703Phase 2 ClinicalUppsala University, Lokon PharmaBiliary Tract Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Melanoma
Details
CD40 ligand expressing MSLN-CAR T cellsPhase 2 ClinicalPla General HospitalSolid tumours
Details
CD40L-augmented Tumor Infiltrating Lymphocytes (H Lee Moffitt Cancer Center & Research Institute)Phase 2 ClinicalH Lee Moffitt Cancer Center & Research InstituteCarcinoma, Non-Small-Cell Lung
Details
LetolizumabBMS-986004; BMS2h-572-633-CT-L2Phase 1 ClinicalBristol-Myers Squibb CompanyPurpura, Thrombocytopenic, Idiopathic; Graft vs Host Disease
Details
TNX-1500TNX-1500Phase 1 ClinicalTonix Pharmaceuticals Holding CorpAutoimmune Diseases; Rejection of organ transplantation; Autoimmune Diseases of the Nervous System
Details
MEM-288MEM-288Phase 1 ClinicalMemgenSolid tumours; Head and Neck Neoplasms; Carcinoma, Merkel Cell; Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma
Details
IBI355IBI-355Phase 1 ClinicalInnovent Biologics(Suzhou) Co LtdSjogren's Syndrome; Lupus Erythematosus, Systemic
Details
APB-A1APB-A1; Lu-AG22515Phase 1 ClinicalAprilBio Co LtdGraves Ophthalmopathy; Neuromyelitis Optica
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland